Formulation and Delivery - Biomolecular
Category: Late Breaking Poster Abstract
												Michael Zaleski
PhD Candidate
University of Pennsylvania
Philadelphia, Pennsylvania, United States
												Michael Zaleski
PhD Candidate
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Liam Chase
Research Specialist
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Jacob Brenner, M.D., Ph.D.
Associate Professor
University of Pennsylvania
Philadelphia, Pennsylvania, United States
A) Schematic of two of the most common conjugation chemistries used to build drug delivery systems: DBCO-azide and SATA-maleimide. Note: A thiol is displayed in the schematic because SATA is deprotected to a thiol group for conjugation to maleimide.  
A) Schematic of hypothesis for mechanism of DBCO influence on complement activation. Due to the hydrophobicity of the DBCO moiety, proteins aggregate on the nanoparticle surface.  Theoretical hydrophobicity of common moieties used in bioconjugation. Theoretical Log(P) was calculated using Swiss ADME online tool. DBCO is two orders-of-magnitude more hydrophobic than SATA and thiol (after SATA deprotection) moieties. 
A) Schematic of hypothesis for mechanism of SATA-maleimide influence on complement activation. Maleimide reacts non-specifically with proteins in plasma, particularly albumin. This leads to a dense protein coating on the surface of the liposome, which initiates complement opsonization.